Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Forward Pharma A/S    FWP

FORWARD PHARMA A/S

(FWP)
My previous session
Most popular
  Report  
 SummaryQuotesChartsNewsCalendarCompanyFinancials 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
02/11/2019 02/12/2019 02/13/2019 02/14/2019 02/15/2019 Date
1.3064(c) 1.46(c) 1.43(c) 1.44(c) 1.38(c) Last
80 182 69 573 16 321 8 482 12 712 Volume
-14.61% +11.76% -2.05% +0.70% -4.17% Change
More quotes
Company
Forward Pharma A/S is a clinical-stage biopharmaceutical company. The Company is engaged in the development of FP187, a formulation of dimethyl fumarate (DMF) for the treatment of several inflammatory and neurological indications, including multiple sclerosis (MS). The Company's clinical candidate,... 
More about the company
Latest news on FORWARD PHARMA A/S
2018FORWARD PHARMA A/S : Provides Update on the Decision of the Federal Circuit in i..
AQ
2018Forward Pharma Provides Update on the Decision of the Federal Circuit in its ..
GL
2018Forward Pharma to Participate in the Ladenburg Thalmann 2018 Healthcare Confe..
GL
2018Forward Pharma Reports Financial and Operational Results from the First Six M..
GL
2018FORWARD PHARMA A/S : to Participate in the LSX Nordic Congress
AQ
2018FORWARD PHARMA A/S : to Participate in the LSX Nordic Congress
AQ
2018FORWARD PHARMA A/S : Appeals the Decision of the Opposition Division to Revoke t..
AQ
2018FORWARD PHARMA A/S : Appeals the Decision of the Opposition Division to Revoke t..
AQ
2018Forward Pharma Appeals the Decision of the Opposition Division to Revoke the ..
GL
2018FORWARD PHARMA A/S : Reports Full-Year 2017 Financial and Operational Results
AQ
More news
Analyst Recommendations on FORWARD PHARMA A/S
More recommendations
Sector news : Bio Therapeutic Drugs
02/15Bayer gains full Vitrakvi rights from Eli Lilly's Loxo
RE
02/12MARKET SNAPSHOT: Stocks Close At 2019 High On Tentative Deal To Avert Governm..
DJ
02/11Regeneron, Sanofi to Offer Praluent at Reduced U.S. List Price
DJ
02/11Sanofi and Regeneron cut list price of cholesterol drug by 60 percent
RE
02/06Eli Lilly Cuts Earnings Forecast on Pending Loxo Acquisition
DJ
More sector news : Bio Therapeutic Drugs
Chart FORWARD PHARMA A/S
Duration : Period :
Forward Pharma A/S Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends FORWARD PHARMA A/S
Short TermMid-TermLong Term
TrendsBullishBearishBearish
Income Statement Evolution
Managers
NameTitle
Claus Bo Svendsen CEO & Principal Financial Officer
Florian Schönharting Chairman
Torsten Rüdiger Goesch Director
Grant Hellier Lawrence Independent Director
Jakob Mosegaard Larsen Director
Sector and Competitors
1st jan.Capitalization (M$)
FORWARD PHARMA A/S76.92%65
GILEAD SCIENCES6.11%87 436
VERTEX PHARMACEUTICALS12.08%48 081
REGENERON PHARMACEUTICALS9.37%45 520
GENMAB-5.01%9 438
SAREPTA THERAPEUTICS INC26.87%9 252